M ore than a century ago an English dermatologist, H utchinson, described the first case o f sarcoidosis. T he systemic nature o f the disease was not recognized at that time. Sarcoidosis was described as a form o f skin disease. D uring the last century, investigators have become aware o f the multisystemic nature o f the disease. In the past two decades, they have also discovered that sarcoidosis is not confined to certain populations. W hether the disease is under-recognized in some other countries due to the high prevalence o f other granulom atous disorders is still a m atter o f discussion. Epidemiological data from India and other eastern countries reveal that sarcoidosis is not as rare as previously thought in developing countries. 1 4 In Turkey, a country that bridges Europe and Asia, the first case o f sarcoidosis was described in 1954. 5 As more physicians came to recognize the disease, the num ber o f reports increased correspondingly, but so far there are no data on the incidence and prevalence o f sarcoidosis in the Turkish population. We gathered all published case series since the first report in 1954 w ith the aim o f profiling the disease in Turkey.
Methods
Since there is no established Turkish medical literature index, all available Turkish pulm onary journals published from 1954 to January 2000 were identified and searched manually. Abstracts presented in international and national meetings were hand searched from the abstract books. We selected all articles and abstracts containing five or more sarcoidosis cases. To ensure that m ost published articles were found, we asked investigators w ith experience in this field about other publications on this subject. To avoid duplication o f data collected and published at different times, the authors were contacted to clarify w hich publication should be included in the current study. Some articles focused on particular aspects o f sarcoidosis and did not report other outcomes. Those articles were analyzed collectively based on the specific measures reported. Therefore, for any given outcom e (like organ involvement frequencies), articles w ithout data on that outcom e were excluded to avoid underestim ation o f that outcome. To assess the status o f sarcoidosis, publications before 1990 were analyzed separately and compared to the data for the entire tim e period (1954 to 2000).
Results
We found 32 reports that met our inclusion criteria.6'37 After exclusion o f articles identified as earlier reports o f the same data, a total o f 29 reports were selected, 11 o f which were abstracts. T he goal was to get specific numbers and a general idea o f several features o f sarcoidosis for the Turkish population. T he 29 reports included data on 1327 patients. T he female/male ratio was 1.83/1. Average ages ranged between 29.8 to 48.38 years. Unfortunately, peak incidence could not be calculated since age was reported as mean data in m ost o f the articles.
Fever was reported in 46 patients. Fatigue and weight loss could not be determ ined precisely since some o f the symptoms were reported as constitutional symptoms. Pulm onary symptoms were the m ost com m on symptoms. Hemoptysis was reported in 4 patients. N one o f the patients were reported to have mycetoma.
A m ong 931 patients in 13 publications that m entioned tuberculin skin test results, 110 patients (24%) had a reactive tuberculin skin test. Serum angiotensin converting enzyme (ACE) was evaluated in 10 papers w ith 185 cases; it was elevated in 52% o f the patients. Hypercalcemia was reported in 25 (6.6%) o f 378 patients. O ther laboratory values such as hematological and other biochemical values were not evaluated due to lack o f data on the laboratory threshold levels.
Nervous system involvement was reported in 12 patients, including 5 w ith central nervous system involvement and 2 w ith facial nerve palsy (Table 1) . Diabetes insipidus was reported in 3 cases. Peripheral lymph node enlargement was reported in 119 patients. Skin involvement was reported in 22 patients. Erythem a nodosum (EN) was reported in 137 patients. N o gastrointestinal tract involvement, (esophagus, appendix, rectum) was reported. Bone involvement was recognized in 22 patients. In 127 patients, arthralgia was present. However, no deforming arthritis was reported.
Radiological stages were m entioned in 20 papers (Table 2) . M ost patients were at stage 1 or 2 at the tim e o f diagnosis. Bronchoscopic m ethods seemed to be the m ost popular diagnostic approach, especially in the last decade (Figure 1) .
Among 32 publications, only 7 were published before 1990.612 As shown in Figure 2 , the num ber o f patients increased trem endously in the last decade. Before 1990, clinical-radiological diagnosis and scalene and peripheral lym ph node biopsies seemed to the choice in diagnosis (Figure 1 ). In the last decade, bronchoscopic biopsy seemed to be the m ost popular tool for diagnosis. Video assisted thoracoscopic (VATS) biopsy has been used in a small group o f patients, but only w ithin the last decade.
Discussion
Sarcoidosis is a multisystemic disease o f unknow n etiology. Diagnosis is usually based on a compatible clinical presentation and supportive histological evidence o f noncaseating granulomas. T he diagnosis is usually a challenge, even for specialists, because o f the presentation, the frequency o f different organ involvement, and the m im icking nature o f the diagnosis. Therefore, knowledge o f the epidemiological features o f the disease is im portant so that physicians can know w hat to expect. There are no estimates o f incidence and prevalence in the Turkish population because the M inistry o f H ealth does not require reporting. T h at the disease is not as rare am ong the Turkish population as once thought is evident from the increasing num ber o f reports. T he lack o f data on incidence and prevalence as well as differences in presentation and frequency o f different organ involvement, led us to summarize the data from these various reports.
T he rate o f positive tuberculin skin tests (23.6%) was higher than reported rates for sarcoidosis. This m ight be explained by routine BCG (Bacille-Calmette-Guerin) vaccination in Turkey, or the high incidence o f tuberculosis O rg a n in volvem ents o th e r th a n p u lm o n a ry p a rench ym a an d in tra th o ra c ic lym ph nodes in sarcoidosis p a tien ts described in th e Turkish m edical lite ra tu re . (TB). However, in India, a country w ith a high TB rate, 90% of patients had a negative tuberculin skin test.3 Some o f our patients with a positive tuberculin skin test may not have had sarcoidosis, but most o f the patients were diagnosed histologically, as shown in Figure 1 . Clinical evidence o f myocardial involvement was reported in 5% of sarcoidosis patients, which seems less than in other countries. T hough electrocardiography is a com m on procedure, routine H olter m onitoring was not performed and therefore underreporting o f cardiac involvement may be possible. For clear evidence o f cardiac involvement, autopsy studies are required.
O rg an involved
T he rate o f erythema nodosum formation was 18.95%, which is higher than the 11% reported for six other European cities.2 Reported rates of erythema nodosum formation am ong sarcoidosis patients in other parts o f the world include 53% in Scandinavia, 31% in Britain, 33% in Barcelona, and 2 to 4% in Japan.2 Neurosarcoidosis was diagnosed in 12 patients (0.9%). This num ber is m uch less than that reported in other series.38 40 Stern and colleagues reported a neurosarcoidosis incidence o f 5.1% with 85% o f cases being African-American. 41 O cular involvement is reported in 11 to 83 percent o f patients.1 In the reports we examined, ocular involvement was not that com m on. In the study by Sen et al routine ocular examination was perform ed in 34 sarcoidosis patients and eye involvement in only 3 (8.8% ).28 In a study by Aytemur et al, only 3 (5%) had eye involvement am ong 60 patients having a routine eye examination.22 Eye involvement in the Turkish population is not as high as reported for other countries. Eye involvement was reported as 27% for London, 32% for Tokyo, 20% for New York and 4% for Eastern Europe.2 T he low rate o f eye involvement in Turkey, which is similar to rates in East Europe, might reflect geographical relationships in the etiology o f the disease.
Lymph node biopsies seemed to be the most popular diagnostic m ethod before 1990. Bronchoscopic methods have become more prom inent in the last decade since their introduction. T he decreased rate o f clinical-radiological diagnosis after 1990 can be explained by the eagerness o f physicians to get histological confirmation. Also the inherent difficulties in diagnosing sarcoidosis in a region with high TB rates m ight explain why the physicians obtain a biopsy. Although evaluation o f therapy results would be very enlightening, we did not gather detailed descriptions o f drug therapy due to the lack o f data on follow-up. However, steroids were the therapy o f choice.
There was a trem endous increase in reported cases after 1990. This increase can be due either to under-recognition o f sarcoidosis before this period or an increased incidence o f the disease in recent years in Turkey. Increased awareness o f the problem and greater recognition o f the disease due to advances in the investigational methods in the last two decades seems to be most likely. As the recognition o f the disease is increased, large centers are being formed for referral o f sarcoidosis patients. Also registries are being formed in these units to get the exact data on the epidemiology o f the disease.
O u r study has many limitations. T he non-standardized format o f the publications and inclusion o f all the articles can cause underestimation o f some o f the organ involvement rates or the most popular diagnostic methods. To avoid underestimation o f organ involvement frequencies we only evaluated papers that included these measures while we were calculating the frequency rates. T he absence o f therapy and follow-up is another lim itation o f our study. T he absence o f a well-established Turkish medical literature index m ight also restrict us from accessing and identifying some o f the publications. However, we tried to minimize this risk by com m unicating personally with investigators in addition to very careful and thorough hand searching. Excluding the case reports may lead to a distorted clinical picture o f the disease since the patients presented in these reports would have unusual clinical presentations. We excluded case reports since the purpose o f the study was to develop an idea o f the general profile o f the disease and also to reduce the risk o f duplicating the num ber o f patients.
In summary, this study shows that recognition o f sarcoidosis in Turkey has increased greatly, especially in the last century. Despite limitations, our study is a useful compilation of 46 years o f sarcoidosis data. Further studies on the geographical distribution and incidence and prevalence are needed for our country.
